A large real-world cohort study published in JAMA Network Open also showed why continuity matters: among adults with overweight or obesity starting GLP-1 receptor agonists, discontinuation within one year was common, especially among patients without type 2 diabetes [JAMA Network Open, 2025]
Keep out of reach of children under three years of age
According to a systematic review and meta-analysis containing several studies and over 150,000 patients with breast cancer, post-diagnosis statin use decreased the risk of breast cancer recurrence and breast cancer mortality [93]
[1] [4] Semaglutide mimics the action of naturally occurring GLP-1, an incretin hormone released from the intestine in response to food intake
Just as weight tends to regain after stopping treatment, alcohol-related benefits may also fade
New and emerging systemic treatments for atopic dermatitis